Results 151 to 160 of about 2,789,158 (281)
ABSTRACT Background People with laryngectomy who use a tracheoesophageal voice prosthesis for communication experience changes to respiratory function resulting in reduced breath support and increased secretions. This impacts tracheoesophageal voice quality and volume.
Freya Sparks+6 more
wiley +1 more source
A CASE OF CHRONIC PSEUDO-MEMBRANOUS BRONCHITIS. [PDF]
Harold A. Johnson
openalex +1 more source
Objective We estimated incidence rates of avoidable hospitalizations by persons with rheumatoid arthritis (RA) relative to the general population. Methods We identified individuals meeting a validated case definition for RA based on International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM) and ICD‐10‐CA codes in years ...
Dani G. Contreras+6 more
wiley +1 more source
An Analysis of the Use of EPA's Clean Air Benefit Estimates in OMB's Draft Report on the Costs and Benefits of Regulation [PDF]
Many advocates of regulatory reform recommend more and better benefit-cost analyses. Perhaps the single most ambitious and sophisticated such analysis ever conducted is the retrospective report on the benefits and costs of clean air recently completed by
Lutter, Randall
core +1 more source
Chronic Obstructive Pulmonary Disease: Outpatient Management [PDF]
Chronic obstructive pulmonary disease has become one of the more common problems which face physicians both in inpatient and outpatient settings. The incidence of the disease and increase in mortality have been documented in a number of studies as have ...
Baker, James P.
core +1 more source
IV. Larynx and trachea: The treatment of chronic bronchitis by means of the ipecacuanha spray [PDF]
Ross
openalex +1 more source
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis
Objective Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, relapsing, inflammatory disease. Management of EGPA predominantly relies on oral corticosteroids (OCS), which are associated with many adverse effects. The phase 3 MIRRA trial demonstrated efficacy and safety of mepolizumab, anti‐interleukin‐5 biologic, for EGPA.
Michael E. Wechsler+34 more
wiley +1 more source
Barnes Hospital Bulletin [PDF]
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1041/thumbnail ...
core +1 more source
Chronic Bronchitis in the Adult as Influenced by a Change of Climate [PDF]
Edward O. Otis
openalex +1 more source
ABSTRACT Background A thorough examination of psychosocial problems and individual patient experiences could contribute to a better understanding of the needs of advanced stage lung cancer patients and the development of personalized care models. Methods This qualitative study investigates the psychosocial issues and end‐of‐life coping strategies ...
Dilek Yıldırım, Vildan Kocatepe
wiley +1 more source